24,25-epoxycholesterol has been researched along with Atherogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, DK; Hong, YF; Kim, H; Kim, HS; Kim, JY; Park, WJ | 1 |
| Guo, CB; Hou, ZG; Liang, Y; Zhang, C | 1 |
1 review(s) available for 24,25-epoxycholesterol and Atherogenesis
| Article | Year |
|---|---|
[Research progress of liver X receptor agonists].
Topics: Amines; Animals; Atherosclerosis; ATP-Binding Cassette Transporters; Benzimidazoles; Cholesterol; Glucose; Humans; Lipid Metabolism; Lipogenesis; Liver X Receptors; Orphan Nuclear Receptors; Quinolines; Sterol Regulatory Element Binding Protein 1 | 2012 |
1 other study(ies) available for 24,25-epoxycholesterol and Atherogenesis
| Article | Year |
|---|---|
Lactobacillus acidophilus K301 Inhibits Atherogenesis via Induction of 24 (S), 25-Epoxycholesterol-Mediated ABCA1 and ABCG1 Production and Cholesterol Efflux in Macrophages.
Topics: Animals; Apolipoprotein A-I; Apolipoproteins E; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; Biological Transport; Cell Line; Cholesterol; Farnesyl-Diphosphate Farnesyltransferase; Gene Expression Regulation; HEK293 Cells; Humans; Intramolecular Transferases; Lactobacillus acidophilus; Liver X Receptors; Macrophages; Mice; Mice, Knockout; Plaque, Atherosclerotic; Probiotics; Signal Transduction; Tetradecanoylphorbol Acetate | 2016 |